As the targeted uptake of NPs is used for the therapy of diseases in a specific manner, we used an A10 RNA aptamer that binds specifically to PSMA, which is expressed on cell surfaces of PCa. This evidence concerns the gene FOLH1 and posterior cortical atrophy.